Delivery Order SPE2DB22D2211-SPE2DB25FSCJM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,651.65. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a contract ceiling value of $1,380.46 and an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside delivery order reflecting a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $4,059.96. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the major pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, valued at $7,285.49 under a firm fixed price contract. This non-competitive delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $11,078.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical supplier to federal...
- The Defense Logistics Agency awarded a $4,973.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 3 mg/0.5 mL pen auto-injectors. This contract, designated as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCJMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,792.32. This is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, executed without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child delivery order under its larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order represents a routine procurement action under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, medical supplies, and specialty pharmaceuticals to support military healthcare programs. As a diabetes management medication, Trulicity supports the Defense Health Agency and other military healthcare systems in treating service members and beneficiaries. AmerisourceBergen Drug Corp's contract portfolio demonstrates its established capability to compete successfully for federal medical procurement requirements and fulfill critical pharmaceutical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/6/25 |